Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Timmins

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Expert Opinion on Therapeutic Patents|September 9, 2017
Deuterated drugs; updates and obviousness analysisGraham S Timmins
Expert Opinion on Drug Discovery|October 1, 2019
What are the challenges in commercial non-tuberculous mycobacteria (NTM) drug discovery and how should we move forward?Graham S Timmins
Trends in Microbiology|March 25, 2015
Detecting virulence and drug-resistance mycobacterial phenotypes in vivoGraham S Timmins
Expert Opinion on Therapeutic Patents|July 29, 2016
Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literatureGraham S Timmins
Expert Opinion on Therapeutic Patents|July 30, 2014
Deuterated drugs: where are we now?Graham S Timmins
Molecular Microbiology|November 1, 2006
Mechanisms of action of isoniazidGraham S Timmins, Vojo Deretic
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2019
Enhancement of lung levels of antibiotics by ambroxol and bromhexineVojo Deretic, Graham S Timmins
Journal of Photochemistry and Photobiology. B, Biology|December 1, 1993
An EPR spin trapping study of albumin protein radicals formed by the photodynamic action of haematoporphyrinG S Timmins, M J Davies
FEMS Microbiology Letters|April 3, 1999
Shift-down in growth rate rather than high cell density induces toxic shock syndrome toxin-1 gene expression in Staphylococcus aureusB S Timmins, K T Holland
Journal of Breath Research|May 17, 2019
Potential for breath test diagnosis of urease positive pathogens in lung infectionsWilliam R Bishai, Graham S Timmins
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Expert Opinion on Therapeutic Patents|September 9, 2017
Deuterated drugs; updates and obviousness analysisGraham S Timmins
Expert Opinion on Drug Discovery|October 1, 2019
What are the challenges in commercial non-tuberculous mycobacteria (NTM) drug discovery and how should we move forward?Graham S Timmins
Trends in Microbiology|March 25, 2015
Detecting virulence and drug-resistance mycobacterial phenotypes in vivoGraham S Timmins
Expert Opinion on Therapeutic Patents|July 29, 2016
Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literatureGraham S Timmins
Expert Opinion on Therapeutic Patents|July 30, 2014
Deuterated drugs: where are we now?Graham S Timmins
Molecular Microbiology|November 1, 2006
Mechanisms of action of isoniazidGraham S Timmins, Vojo Deretic
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2019
Enhancement of lung levels of antibiotics by ambroxol and bromhexineVojo Deretic, Graham S Timmins
Journal of Photochemistry and Photobiology. B, Biology|December 1, 1993
An EPR spin trapping study of albumin protein radicals formed by the photodynamic action of haematoporphyrinG S Timmins, M J Davies
FEMS Microbiology Letters|April 3, 1999
Shift-down in growth rate rather than high cell density induces toxic shock syndrome toxin-1 gene expression in Staphylococcus aureusB S Timmins, K T Holland
Journal of Breath Research|May 17, 2019
Potential for breath test diagnosis of urease positive pathogens in lung infectionsWilliam R Bishai, Graham S Timmins
Pageof 8